NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors
Authors
Keywords
-
Journal
OncoImmunology
Volume -, Issue -, Pages e1330235
Publisher
Informa UK Limited
Online
2017-05-19
DOI
10.1080/2162402x.2017.1330235
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic lymphocytic leukemia (CLL)-Then and now
- (2016) Kanti R. Rai et al. AMERICAN JOURNAL OF HEMATOLOGY
- Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia
- (2016) Julio C. Chavez et al. LEUKEMIA RESEARCH
- Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells
- (2016) Olle Werlenius et al. Oncotarget
- NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma
- (2016) Helen M. Parry et al. Oncotarget
- Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia
- (2016) Emily M. McWilliams et al. OncoImmunology
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function
- (2015) Heinrich Schlums et al. IMMUNITY
- Epigenetic Modification and Antibody-Dependent Expansion of Memory-like NK Cells in Human Cytomegalovirus-Infected Individuals
- (2015) Jaewon Lee et al. IMMUNITY
- Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time
- (2015) Misty R. Jenkins et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Neutralization of (NK-cell-derived) B-cell activating factor by Belimumab restores sensitivity of chronic lymphoid leukemia cells to direct and Rituximab-induced NK lysis
- (2015) J Wild et al. LEUKEMIA
- Cytokine therapy reverses NK cell anergy in MHC-deficient tumors
- (2014) Michele Ardolino et al. JOURNAL OF CLINICAL INVESTIGATION
- CD27 Defines Phenotypically and Functionally Different Human NK Cell Subsets
- (2014) M. T. M. Vossen et al. JOURNAL OF IMMUNOLOGY
- Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
- (2014) Valentin Goede et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expansion of NK Cells and Reduction of NKG2D Expression in Chronic Lymphocytic Leukemia. Correlation with Progressive Disease
- (2014) Leticia Huergo-Zapico et al. PLoS One
- NK cell self tolerance, responsiveness and missing self recognition
- (2014) Nataliya Shifrin et al. SEMINARS IN IMMUNOLOGY
- Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity
- (2013) K. S. Reiners et al. BLOOD
- CD27 engagement by a soluble CD70 protein enhances non-cytolytic antiviral activity of CD56bright natural killer cells by IFN-γ secretion
- (2013) Young-Soon Jang et al. CLINICAL IMMUNOLOGY
- A comprehensive analysis of the binding of anti-KIR antibodies to activating KIRs
- (2013) K Czaja et al. GENES AND IMMUNITY
- Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients
- (2013) Paulina Własiuk et al. HUMAN IMMUNOLOGY
- Recombinant Human IL-15 Trans-Presentation by B Leukemic Cells from Chronic Lymphocytic Leukemia Induces Autologous NK Cell Proliferation Leading to Improved Anti-CD20 Immunotherapy
- (2013) E. Laprevotte et al. JOURNAL OF IMMUNOLOGY
- Fratricide of natural killer cells dressed with tumor-derived NKG2D ligand
- (2013) Kyohei Nakamura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection
- (2013) A. W. MacFarlane et al. Cancer Immunology Research
- Combination Immune Therapies to Enhance Anti-Tumor Responses by NK Cells
- (2013) Ashley Mentlik James et al. Frontiers in Immunology
- T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production
- (2012) J. C. Riches et al. BLOOD
- Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer
- (2012) A. G. Ramsay et al. BLOOD
- Primary B-CLL Resistance to NK Cell Cytotoxicity can be Overcome In Vitro and In Vivo by Priming NK Cells and Monoclonal Antibody Therapy
- (2012) Caroline Veuillen et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Comprehensive Analysis of NKG2D Ligand Expression and Release in Leukemia: Implications for NKG2D-Mediated NK Cell Responses
- (2012) J. Hilpert et al. JOURNAL OF IMMUNOLOGY
- Definition and characterization of the systemic T-cell dysregulation in untreated indolent B-cell lymphoma and very early CLL
- (2011) P. Christopoulos et al. BLOOD
- Expansion of a CD8+PD-1+ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression
- (2011) C. Nunes et al. CLINICAL CANCER RESEARCH
- Expression of natural killer cell activating receptors in patients with chronic lymphocytic leukaemia
- (2011) Régis T. Costello et al. IMMUNOLOGY
- Glucocorticoid-induced TNFR-related protein (GITR) ligand modulates cytokine release and NK cell reactivity in chronic lymphocytic leukemia (CLL)
- (2011) C Buechele et al. LEUKEMIA
- Interleukin-21 and rituximab enhance NK cell functionality in patients with B-cell chronic lymphocytic leukaemia
- (2011) Christian W. Eskelund et al. LEUKEMIA RESEARCH
- Natural killer cells and cancer: Regulation by the killer cell Ig-like receptors (KIR)
- (2010) Amanda K. Purdy et al. CANCER BIOLOGY & THERAPY
- Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies
- (2010) M Le Garff-Tavernier et al. LEUKEMIA
- The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia
- (2010) H Nückel et al. LEUKEMIA
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia
- (2008) Shanique Palmer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Lenalidomide Enhances Natural Killer Cell and Monocyte-Mediated Antibody-Dependent Cellular Cytotoxicity of Rituximab-Treated CD20+ Tumor Cells
- (2008) L. Wu et al. CLINICAL CANCER RESEARCH
- Application of CD27 as a marker for distinguishing human NK cell subsets
- (2008) A. Silva et al. INTERNATIONAL IMMUNOLOGY
- NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G
- (2008) G Maki et al. LEUKEMIA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started